Why AbCellera Biologics (ABCL) Is Up 5.5% After New Jazz T-Cell Engager Collaboration Agreement Simply Wall St 12:01 Sat, 20 Jun
Jazz and AbCellera sign deal for T-cell engagers in solid tumours Pharmaceutical Business Review 10:49 Thu, 18 Jun
AbCellera Finds Latest Antibody Discovery Partner In Jazz Scrip Pharma Intelligence 22:13 Wed, 17 Jun
Jazz taps Abcellera in potential $4B antibody discovery deal BioWorld 21:48 Wed, 17 Jun Article paywall
Jazz Pharmaceuticals Signs Multi-Program Antibody Discovery Deal With AbCellera RTT News 13:32 Wed, 17 Jun
Jazz Pharmaceuticals And AbCellera Join Forces To Develop Next-Generation Cancer Antibodies RTT News 13:17 Wed, 17 Jun
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies Business Wire (Press Release) 12:00 Wed, 17 Jun
Wall Street Analysts Think ABCELLERA BIOLG (ABCL) Could Surge 85.59%: Read This Before Placing a Bet Zacks 15:58 Mon, 08 Jun
AbCellera Appoints Dr. Victor Sandor to its Board of Directors Business Wire (Press Release) 14:02 Fri, 05 Jun
After Golden Cross, AbCellera Biologics Inc. (ABCL)'s Technical Outlook is Bright Zacks 16:02 Fri, 29 May